BC
TEVA icon

Burney Company’s Teva Pharmaceuticals TEVA Stock Holding History

Burney Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,690
Closed -$569K – 402
2016
Q4 		$569K Sell
15,690
-10,839
-41% -$433K 0.04% 256
2016
Q3 		$1.29M Sell
26,529
-25,941
-49% -$1.35M 0.09% 186
2016
Q2 		$2.64M Buy
52,470
+2,312
+5% +$123K 0.19% 130
2016
Q1 		$2.68M Buy
50,158
+560
+1% +$32.9K 0.2% 128
2015
Q4 		$3.27M Buy
49,598
+58
+0.1% +$3.58K 0.24% 111
2015
Q3 		$2.8M Buy
49,540
+1,048
+2% +$68K 0.22% 122
2015
Q2 		$2.87M Buy
48,492
+12,506
+35% +$771K 0.19% 128
2015
Q1 		$2.24M Buy
35,986
+4,853
+16% +$282K 0.15% 145
2014
Q4 		$1.79M Buy
31,133
+24,133
+345% +$1.34M 0.14% 157
2014
Q3 		$376K Buy
7,000
+275
+4% +$14.6K 0.03% 302
2014
Q2 		$353K Sell
6,725
-480
-7% -$24.5K 0.03% 319
2014
Q1 		$381K Sell
7,205
-53
-0.7% -$2.45K 0.03% 306
2013
Q4 		$291K Sell
7,258
-12,086
-62% -$476K 0.03% 353
2013
Q3 		$731K Sell
19,344
-6,159
-24% -$240K 0.08% 226
2013
Q2 		$1M Buy
+25,503
New +$993K 0.12% 184

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Burney Company's TEVA Position: Q1 2017 in Review

Burney Company sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 15,690 shares — an estimated $569K sold.

Burney Company first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $3.27M in Q4 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Burney Company reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Burney Company sold 15,690 Teva Pharmaceuticals shares in Q1 2017, an estimated $569K.
  • Burney Company first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Burney Company's Teva Pharmaceuticals position peaked at $3.27M in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Burney Company's 13F filing for Q1 2017, filed 11 May 2017.